However, as a critical tumor suppressor, FOXO1 expression has been observed to be undetectable or extremely low in certain tissues, including prostate, breast and colon cancer cells (24–26), which suggests that low levels of FOXO1 may be one of the factors contributing to the oncogenesis and progression of breast carcinoma. This evidence concerns the gene FOXO1 and breast carcinoma.